PRV Research Group https://validator.w3.org/feed/docs/rss2.html Research Group PRV Lab Alumni Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation Supercritical processed Starch nanosponge as a carrier for enhancement of dissolution and pharmacological efficacy of Fenofibrate Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate Effect of Lipid Composition in Propofol Formulations: Decisive Component in Reducing the Free Propofol Content and Improving Pharmacodynamic Profiles In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)–PEG–Doxorubicin for Targeted Cancer Therapy Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics Industry Collaboration Contact Blog Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin Patents Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic Liposomes Bioequivalence studies of angiotensin converting enzyme inhibitors: Part – I (lisinopril) Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies Publications Home Research Area